Growth Metrics

Indivior Pharmaceuticals (INDV) Change in Acquisitions & Divestments (2022 - 2026)

Indivior Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 5 years, most recently at $6.0 million for Q1 2026.

  • For Q1 2026, Change in Acquisitions & Divestments changed 0.0% year-over-year to $6.0 million; the TTM value through Mar 2026 reached $19.0 million, up 176.0%, while the annual FY2025 figure was $19.0 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 was $6.0 million at Indivior Pharmaceuticals, up from $5.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $46.0 million in Q3 2024 and troughed at -$95.0 million in Q4 2023.
  • A 5-year average of $2.8 million and a median of $6.0 million in 2025 define the central range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 520.0% in 2023 and fell as far as 891.67% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $12.0 million in 2022, then crashed by 891.67% to -$95.0 million in 2023, then grew by 7.37% to -$88.0 million in 2024, then skyrocketed by 105.68% to $5.0 million in 2025, then rose by 20.0% to $6.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for INDV at $6.0 million in Q1 2026, $5.0 million in Q4 2025, and $3.0 million in Q3 2025.